Democratic leaders struggling to satisfy both progressive and moderate factions’ demands are still trying to resolve divisions over scaling back the expansive health care policy wish list in their $3.5 trillion budget reconciliation package. A smattering of members in both chambers have concerns with key issues ranging from drug pricing to Medicare spending, while Democratic ...

There are many theories about what is (and what is not) a good indicator of a stock’s future growth (or decline). However, it is important to note that investment articles – for good reason – usually include an advisory about past performance not being a recommendation or guarantee of any future outcome or profit. Investing is a ...

California in August gave the state’s health care workers an ultimatum: Get vaccinated by Sept. 30 or submit to twice-weekly COVID-19 testing. So far, it appears to be working. Three major Sacramento-area health care systems say vaccination rates among employees are now higher than the general population. “It’s more than good, it’s very good,” said Dr. ...

Means-testing Medicare, a long-running controversy in health policy debates, is re-emerging as a major source of tension for Democrats seeking a path forward on their stalled social spending package. Centrist lawmakers are demanding that an expansion of the program to cover dental, vision and hearing care be limited to the poorest Americans, to pare the ...

Employer group health plans cannot deny benefits to customers who have not gotten the COVID-19 vaccine but can offer premium discounts to customers who decide to get the shot, new guidance from the Centers for Medicare & Medicaid Services (CMS) said. But plans that increase premiums on the unvaccinated will have that increase count toward ...

Americans are paying pharmaceutical companies more for the world's 20 blockbuster drugs than the rest of the world combined, according to an analysis of company financial filings by Public Citizen.